Three independent discounted-cash-flow-style models value CONMED Corporation every trading day. 1 of 3 currently price CNMD above its market price.
| Free Cash Flow model | $51.39 |
| Excess Profit model | $-1.27 |
| Residual Earnings model | $-1.26 |
| Dividend Discount model | — |
| Piotroski F-Score | 6 / 9 |
| Return on invested capital | +4.0% |
| Net debt / EBITDA | 9.1× |
| Gross margin | +54.6% |
| Revenue CAGR | +9.6% |
| Cash conversion | 3.6× |
| Dividend yield | — |
| Buyback yield | -0.6% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open CNMD in StockKitty